world cancer report - iarc
world cancer report - iarc
world cancer report - iarc
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
cava involvement reduces five-year survival<br />
rates to 25-50%, whilst regional<br />
lymph node involvement or extracapsu-<br />
REFERENCES<br />
1. Richie JP, Kantoff PW, Shapiro CL (1997) Renal cell carcinoma.<br />
In: Holland JF, Bast RC, Morton DL, Frei E, Kufe<br />
DW, Weichselbaum RR eds, Cancer Medicine, Williams and<br />
Wilkins.<br />
2. Godley PA, Ataga KI (2000) Renal cell carcinoma. Curr<br />
Opin Oncol, 12: 260-264.<br />
3. Ferlay J, Bray F, Parkin DM, Pisani P, eds (2001)<br />
Globocan 2000: Cancer Incidence and Mortality Worldwide<br />
(IARC Cancer Bases No. 5), Lyon, IARCPress.<br />
4. McLaughlin JK, Blot WJ, Devesa SS, Fraumeni FJ (1996)<br />
Renal <strong>cancer</strong>. In: Schottenfeld D, Fraumeni, JFJ eds, Cancer<br />
Epidemiology and Prevention, New York, Oxford University<br />
Press, 1142-1155.<br />
5. Chow WH, Devesa SS, Warren JL, Fraumeni JF, Jr.<br />
(1999) Rising incidence of renal cell <strong>cancer</strong> in the United<br />
States. JAMA, 281: 1628-1631.<br />
6. Doll R (1996) Cancers weakly related to smoking. Br<br />
Med Bull, 52: 35-49.<br />
7. Schmieder RE, Delles C, Messerli FH (2000) Diuretic<br />
therapy and the risk for renal cell carcinoma. J Nephrol, 13:<br />
343-346.<br />
8. Watkin N, Christmas TJ (1998) Renal Tumours. In:<br />
Morris D, Kearsley J, Williams C eds, Cancer: a comprehensive<br />
clinical guide, Harwood Academic Publishers.<br />
9. Bernheim A, Vagner-Capodano A, Couturier J, et le<br />
Groupe Francais de Cytogenetique Oncologique (2000) De<br />
264 Human <strong>cancer</strong>s by organ site<br />
lar extension also indicates a much<br />
reduced rate of 15-50%. The presence of<br />
distant metastases or stage IV <strong>cancer</strong><br />
la cytogénétique à la cytogénomie oncologique.<br />
Medecine/Sciences, 16: 528-539.<br />
10. van den Berg, Dijkhuizen T (1999) Classification of<br />
renal cell <strong>cancer</strong> based on (cyto)genetic analysis. Contrib<br />
Nephrol, 128: 51-61.<br />
11. Couch V, Lindor NM, Karnes PS, Michels VV (2000)<br />
von Hippel-Lindau disease. Mayo Clin Proc, 75: 265-272.<br />
12. Hata J (1999) Wilms tumor and the WT1 gene. Contrib<br />
Nephrol, 128: 62-74.<br />
13. Motzer RJ, Russo P (2000) Systemic therapy for renal<br />
cell carcinoma. J Urol, 163: 408-417.<br />
14. Vogelzang NJ, Stadler WM (1998) Kidney <strong>cancer</strong>.<br />
Lancet, 352: 1691-1696.<br />
carries a very poor prognosis (5% fiveyear<br />
survival rate) [1].<br />
WEBSITES<br />
NCI Kidney Cancer Homepage:<br />
http://www.<strong>cancer</strong>.gov/<strong>cancer</strong>_information/<strong>cancer</strong>_type/<br />
kidney/<br />
The Kidney Cancer Association (USA):<br />
http://www.nkca.org/